Raia Drogasil (BOVESPA:RADL3) - Aktienkurs, Nachrichten und Analyse

RADL3 Aktienübersicht

Raia Drogasil S.A. ist im Einzelhandel mit Arzneimitteln, Parfüm, Körperpflege- und Schönheitsprodukten, Kosmetika, Dermokosmetika und Spezialarzneimitteln in Brasilien tätig.

Über das Unternehmen

RADL3 grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	0/6
Künftiges Wachstum	5/6
Vergangene Leistung	2/6
Finanzielle Gesundheit	4/6
Dividenden	0/6

Belohnungen

Prognostiziertes Gewinnwachstum 25.44% pro Jahr

Die Erträge sind in den letzten 5 Jahren um 14.1% pro Jahr gestiegen.

Risikoanalyse

Hat einen hohen Schuldenstand

Raia Drogasil S.A. Wettbewerber

Empreendimentos Pague Menos

BOVESPA:PGMN3

R$1.8b

Dimed Distribuidora de Medicamentos

BOVESPA:PNVL3

R$1.5b

Grupo Mateus

BOVESPA:GMAT3

R$17.4b

d1000 Varejo Farma Participações

BOVESPA:DMVF3

R$360.3m

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Raia Drogasil
Historische Aktienkurse
Aktueller Aktienkurs	R$27.56
52-Wochen-Hoch	R$30.40
52-Wochen-Tief	R$24.30
Beta	0.33
11 Monat Veränderung	-2.96%
3 Monate Veränderung	9.45%
1 Jahr Veränderung	0.073%
33 Jahre Veränderung	9.86%
5 Jahre Veränderung	57.82%
Veränderung seit IPO	4,094.51%

Aktuelle Nachrichten und Updates

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Aug 10

With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For

Jul 13

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Apr 08

Recent updates

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Aug 10

Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors

Dec 29

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

Dec 12

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

Nov 27

Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Stalled

Oct 27

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

Sep 07

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Aug 19

Here's What To Make Of Raia Drogasil's (BVMF:RADL3) Decelerating Rates Of Return

Jul 18

Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?

Jun 03

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

May 13

Returns At Raia Drogasil (BVMF:RADL3) Appear To Be Weighed Down

Apr 10

The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts

Mar 10

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Feb 27

Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Hit The Brakes

Jan 07

Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors

Dec 07

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Nov 22

Raia Drogasil (BVMF:RADL3) Could Be Struggling To Allocate Capital

Sep 08

Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors

Aug 24

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Aug 09

There Are Reasons To Feel Uneasy About Raia Drogasil's (BVMF:RADL3) Returns On Capital

Jun 09

With EPS Growth And More, Raia Drogasil (BVMF:RADL3) Is Interesting

May 25

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

May 10

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Feb 24

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Feb 09

Some Investors May Be Worried About Raia Drogasil's (BVMF:RADL3) Returns On Capital

Dec 07

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Nov 19

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Nov 04

Returns On Capital At Raia Drogasil (BVMF:RADL3) Paint A Concerning Picture

Sep 01

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

Aug 17

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Jul 28

Raia Drogasil (BVMF:RADL3) Will Will Want To Turn Around Its Return Trends

May 10

We Think Raia Drogasil (BVMF:RADL3) Can Stay On Top Of Its Debt

Mar 10

Do Institutions Own Raia Drogasil S.A. (BVMF:RADL3) Shares?

Feb 16

Is Raia Drogasil S.A.'s (BVMF:RADL3) Recent Performance Tethered To Its Attractive Financial Prospects?

Jan 29

You Have To Love Raia Drogasil S.A.'s (BVMF:RADL3) Dividend

Jan 11

Did Business Growth Power Raia Drogasil's (BVMF:RADL3) Share Price Gain of 253%?

Dec 24

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Dec 03

Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet

Aug 25

Should We Be Excited About The Trends Of Returns At Raia Drogasil (BVMF:RADL3)?

Aug 12

What Kind Of Shareholders Hold The Majority In Raia Drogasil S.A.'s (BVMF:RADL3) Shares?

Aug 12

What You Can Learn From Raia Drogasil S.A.'s (BVMF:RADL3) P/E

Jul 30

Raia Drogasil (BVMF:RADL3) Is Growing Earnings But Are They A Good Guide?

Jul 17

Is Raia Drogasil S.A.'s(BVMF:RADL3) Recent Stock Performance Tethered To Its Strong Fundamentals?

Jul 04

Aktionärsrenditen

	RADL3	BR Consumer Retailing	BR Markt
7D	-1.1%	-2.0%	-0.005%
1Y	0.07%	-5.6%	9.3%

Rendite im Vergleich zur Industrie: RADL3 übertraf die Branche BR Consumer Retailing , die im vergangenen Jahr eine Rendite von -19.9 erzielte.

Rendite vs. Markt: RADL3 hinter dem Markt BR zurück, der im vergangenen Jahr eine Rendite von 9.5 erzielte.

Preisvolatilität

Is RADL3's price volatile compared to industry and market?
RADL3 volatility
RADL3 Average Weekly Movement	3.7%
Consumer Retailing Industry Average Movement	4.7%
Market Average Movement	4.6%
10% most volatile stocks in BR Market	9.2%
10% least volatile stocks in BR Market	2.3%

Stabiler Aktienkurs: RADL3 hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: RADL3Die wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1905	59,341	Marcílio Pousada	rdsaude.com.br

Raia Drogasil S.A. ist im Einzelhandel mit Arzneimitteln, Parfüm, Körperpflege- und Schönheitsprodukten, Kosmetika, Dermokosmetika und Spezialarzneimitteln in Brasilien tätig. Das Unternehmen vertreibt seine Produkte über Geschäfte, Telesales und Callcenter in den Bundesstaaten São Paulo, Tocantins und Pernambuco. Das Unternehmen wurde 1905 gegründet und hat seinen Hauptsitz in São Paulo, Brasilien.

Raia Drogasil S.A.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Raia Drogasil im Vergleich zum Marktanteil des Unternehmens?
RADL3 grundlegende Statistiken
Marktanteil	R$47.27b
Gewinn(TTM)	R$1.04b
Umsatz(TTM)	R$36.39b

45.5x

Kurs-Gewinn-Verhältnis

1.3x

Kurs-Umsatz-Verhältnis

Ist RADL3 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
RADL3 Gewinn- und Verlustrechnung (TTM)
Einnahmen	R$36.39b
Kosten der Einnahmen	R$25.52b
Bruttogewinn	R$10.87b
Sonstige Ausgaben	R$9.83b
Umsatz	R$1.04b

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

Nov 05, 2024

Gewinn per Aktie (EPS)	0.61
Bruttomarge	29.86%
Nettogewinnspanne	2.86%
Schulden/Eigenkapital-Verhältnis	55.2%

Wie hat sich RADL3 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

0.8%

Aktuelle Dividendenrendite

17%

Ausschüttungsquote

RADL3 Aktienübersicht

Belohnungen

Risikoanalyse

Raia Drogasil S.A. Wettbewerber

BOVESPA:PGMN3

R$1.8b

BOVESPA:PNVL3

R$1.5b

BOVESPA:GMAT3

R$17.4b

BOVESPA:DMVF3

R$360.3m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For

Now 20% overvalued

Upcoming dividend of R$0.049 per share

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Recent updates

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For

Now 20% overvalued

Upcoming dividend of R$0.049 per share

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Does Raia Drogasil (BVMF:RADL3) Deserve A Spot On Your Watchlist?

Full year 2023 earnings released

Investors Met With Slowing Returns on Capital At Raia Drogasil (BVMF:RADL3)

Raia Drogasil S.A., Annual General Meeting, Apr 17, 2024

Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Stalled

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

Raia Drogasil S.A. to Report Q3, 2023 Results on Oct 31, 2023

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Second quarter 2023 earnings: Revenues exceed analyst expectations

Here's What To Make Of Raia Drogasil's (BVMF:RADL3) Decelerating Rates Of Return

Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of R$0.048 per share at 0.9% yield

Returns At Raia Drogasil (BVMF:RADL3) Appear To Be Weighed Down

The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts

Full year 2022 earnings: EPS exceeds analyst expectations

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Raia Drogasil S.A. to Report Q4, 2022 Results on Mar 07, 2023

Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Hit The Brakes

Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Less than half of directors are independent

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Raia Drogasil S.A. to Report Q3, 2022 Results on Oct 31, 2022

Raia Drogasil (BVMF:RADL3) Could Be Struggling To Allocate Capital

Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Second quarter 2022 earnings: Revenues miss analyst expectations

Raia Drogasil S.A. to Report Q2, 2022 Results on Jul 29, 2022

There Are Reasons To Feel Uneasy About Raia Drogasil's (BVMF:RADL3) Returns On Capital

With EPS Growth And More, Raia Drogasil (BVMF:RADL3) Is Interesting

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Raia Drogasil S.A. to Report Q1, 2022 Results on May 03, 2022

Full year 2021 earnings: EPS misses analyst expectations

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Raia Drogasil S.A. to Report Q4, 2021 Results on Feb 22, 2022

Some Investors May Be Worried About Raia Drogasil's (BVMF:RADL3) Returns On Capital

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Third quarter 2021 earnings released

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Returns On Capital At Raia Drogasil (BVMF:RADL3) Paint A Concerning Picture

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

Second quarter 2021 earnings released

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

First quarter 2021 earnings released

Raia Drogasil (BVMF:RADL3) Will Will Want To Turn Around Its Return Trends

Erträge & Einnahmen